Health Turmoil: Rising TB, Strategic Drug Reviews, and Food Safety Shifts

A 10% surge in child TB infections in Europe has prompted urgent WHO action, European regulators are evaluating GSK's drug for expanded use, USAID funding cuts may worsen HIV infection rates, and the U.S. is adapting egg imports during a bird flu outbreak. Legal and corporate news features prominently too.

The World Health Organization urges immediate measures as child tuberculosis cases in Europe rise by 10% this year, highlighting an alarming trend in ongoing disease transmission across the region.

Simultaneously, European officials evaluate GSK's asthma medication Nucala for potential application in treating chronic obstructive pulmonary disease, while the US considers Brazilian egg imports amid soaring prices due to bird flu.

Meanwhile, funding cuts could result in 2,000 new HIV infections daily, DNA testing firm 23andMe files for bankruptcy, and Bayer faces a hefty $2.1 billion verdict over cancer claims linked to its Roundup weed killer.

(With inputs from agencies.)